Biomarker A+T−: is this Alzheimer’s disease or not? A combined CSF and pathology study

The biological definition of Alzheimer’s disease using CSF biomarkers requires abnormal levels of both amyloid (A) and tau (T). However, biomarkers and corresponding cutoffs may not always reflect the presence or absence of pathology. Previous studies suggest that up to 32% of individuals with autop...

Descripción completa

Detalles Bibliográficos
Autores principales: Vromen, Eleonora M, de Boer, Sterre C M, Teunissen, Charlotte E, Rozemuller, Annemieke, Sieben, Anne, Bjerke, Maria, Visser, Pieter Jelle, Bouwman, Femke H, Engelborghs, Sebastiaan, Tijms, Betty M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976983/
https://www.ncbi.nlm.nih.gov/pubmed/35511164
http://dx.doi.org/10.1093/brain/awac158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976983/
https://www.ncbi.nlm.nih.gov/pubmed/35511164
http://dx.doi.org/10.1093/brain/awac158

Ejemplares similares